Living Cell Technology to begin phase II diabetes trial
30 March, 2010 by Tim DeanNew clinical trial for type I diabetes treatment using xenotransplantation of pig cells to begin in New Zealand.
Ocean microbes combat plastic pollution
29 March, 2010 by Staff WritersResearchers are investigating microbes that break down plastics as a means of controlling ocean pollution.
Compound screening for drug development made simpler
26 March, 2010 by Staff WritersNew filters weed out false positive drug candidates making drug discovery cheaper and more efficient.
EU patents to arrive in two years
25 March, 2010 by Staff WritersAn effective European Union-wide patent and patent court has been on everyone’s wish list since the 1970s – and the dream may finally be coming true.
Phosphagenics partners with US firm to market OTC drugs
24 March, 2010 by Tim DeanPhosphagenics and US-based Quigley form joint venture, Phusion Laboratories, to market over-the-counter products.
ChemGenex hits FDA speed bump for Omapro
23 March, 2010 by Tim DeanFDA rules that a diagnostic test is needed prior to approval of anti-leukaemia drug, Omapro.
Australian biotech market watch 19/03/10
19 March, 2010 by Tim DeanCochlar, CSL, ResMed, Living Cell Technology, Mesoblast
Biotechnology Directory opens portal to the life sciences industry
18 March, 2010 by Staff WritersAustralian Life Scientist Biotechnology Directory launches providing portal to the Australian biotechnology community.
AusBiotech announces Australasian Life Science Investment Summit
17 March, 2010 by Staff WritersFollowing success from last year, AusBiotech will hold another investment summit in October.
Targeted antibiotics tackle bacterial resistance
16 March, 2010 by Staff WritersA new approach to combating antibiotic resistance draws on lessons learned from targeted therapies for cancer.
ResMed slapped with anti-trust suit in US
15 March, 2010 by Tim DeanResMed and rival challenged by disgruntled distributor over access to products.
Australian biotech market watch 15/03/10
15 March, 2010 by Tim DeanLiving Cell Technology, Ansell, ChemGenex, Biota Holdings, Sonic Healthcare, ResMed, CSL
Feature: Centre for Kinomics shakes up drug discovery
12 March, 2010 by Tim DeanAdam McCluskey and Phillip Robinson are embarking on an ambitious project that could radically change the way drug research is conducted in Australia.
Aim Lab launches Tecan Australian venture
12 March, 2010 by Tim DeanTecan Australia to provide Tecan laboratory instruments and support in Oceania through AimLab.
Living Cell Technologies implant given regulatory tick in Russia
10 March, 2010 by Tim DeanBrings Living Cell Technologies closer to commercialisation of xenotransplantation device to treat diabetes.
